The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.
作者信息
Aziz Muhammad, Fatima Rawish, Haghbin Hossein, Lee-Smith Wade, Nawras Ali
机构信息
Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USA.
University of Toledo Libraries, Toledo, OH, USA.
出版信息
Inflamm Bowel Dis. 2020 Sep 18;26(10):e132-e133. doi: 10.1093/ibd/izaa170.
Abstract
摘要
相似文献
1
The Incidence and Outcomes of COVID-19 in IBD Patients: A Rapid Review and Meta-analysis.炎症性肠病患者中新型冠状病毒肺炎的发病率及转归：一项快速综述与荟萃分析
Inflamm Bowel Dis. 2020 Sep 18;26(10):e132-e133. doi: 10.1093/ibd/izaa170.
2
Excessive anxiety in IBD patients is unnecessary for COVID-19.炎症性肠病患者对新冠病毒过度焦虑是没有必要的。
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):e121-e122. doi: 10.1016/j.clinre.2020.03.001. Epub 2020 May 12.
3
Low frequency of COVID-19 in inflammatory bowel diseases.炎症性肠病中新冠病毒病的低发病率
Dig Liver Dis. 2020 Nov;52(11):1234-1235. doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.
4
Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.致编辑的信的回复：炎症性肠病患者中新冠病毒病的发病率和结局：快速综述与荟萃分析
Inflamm Bowel Dis. 2020 Sep 18;26(10):e127. doi: 10.1093/ibd/izaa172.
5
Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis.定量蛋白质组学分析慢性肠炎患者肠道中 SARS-CoV-2 受体的表达。
Yonsei Med J. 2020 Oct;61(10):891-894. doi: 10.3349/ymj.2020.61.10.891.
6
Will COVID-19 Infection be Less Severe in Ulcerative Colitis Than in Crohn's Patients, Due to a Lower Rate of Smokers?由于溃疡性结肠炎患者中吸烟者的比例较低，COVID-19感染在溃疡性结肠炎患者中的严重程度是否会低于克罗恩病患者？
J Crohns Colitis. 2020 Nov 7;14(11):1648. doi: 10.1093/ecco-jcc/jjaa077.
7
Could DIZE be the answer to COVID-19?二氢杨梅素（DIZE）会是新冠病毒病（COVID-19）的解决方案吗？
Maturitas. 2020 Oct;140:83-84. doi: 10.1016/j.maturitas.2020.07.002. Epub 2020 Jul 2.
8
Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization.2019冠状病毒病疫情期间炎症性肠病的管理：来自欧洲克罗恩病和结肠炎组织的一项调查
Gastroenterology. 2020 Jul;159(1):14-19.e3. doi: 10.1053/j.gastro.2020.04.059. Epub 2020 Apr 30.
9
Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.S3指南增编：克罗恩病和溃疡性结肠炎——2019冠状病毒病大流行期间炎症性肠病患者的管理：开放式问答
Z Gastroenterol. 2020 Oct;58(10):982-1002. doi: 10.1055/a-1234-8079. Epub 2020 Oct 9.
10
Oral cancer and ACE2 receptor of SARS-CoV-2.口腔癌与新型冠状病毒2的血管紧张素转换酶2受体
Oral Oncol. 2020 Sep;108:104920. doi: 10.1016/j.oraloncology.2020.104920. Epub 2020 Jul 21.
引用本文的文献
1
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study.炎症性肠病（IBD）患者的新型冠状病毒2型（SARS-CoV-2）疫苗接种——IBD治疗是否会对SARS-CoV-2抗体产生负面影响？一项单中心前瞻性研究。
Prz Gastroenterol. 2024;19(2):198-205. doi: 10.5114/pg.2023.130126. Epub 2023 Jul 27.
2
Inflammatory bowel diseases and the clinical course of coronavirus disease 2019 - a Polish single-centre experience from the pre-vaccine era.炎症性肠病与2019冠状病毒病的临床病程——波兰疫苗接种前时代的单中心经验
Prz Gastroenterol. 2023;18(4):409-415. doi: 10.5114/pg.2023.133479. Epub 2023 Dec 8.
3
Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review.黄酮类化合物槲皮素和水飞蓟素在病毒相关性炎症性肠病中的保护作用：最新综述。
Arch Microbiol. 2023 May 30;205(6):252. doi: 10.1007/s00203-023-03590-0.
4
Association Between Inflammatory Bowel Disease and Viral Infections.炎症性肠病与病毒感染的关联。
Curr Microbiol. 2023 Apr 27;80(6):195. doi: 10.1007/s00284-023-03305-0.
5
COVID-19 and Inflammatory Bowel Disease.新型冠状病毒肺炎与炎症性肠病。
Gastroenterol Clin North Am. 2023 Mar;52(1):103-113. doi: 10.1016/j.gtc.2022.10.005. Epub 2022 Oct 31.
6
Risk of COVID-19 Infection After Full Immunization in Patients With Inflammatory Bowel Disease on Treatment: A Research Network Analysis.炎症性肠病患者在接受治疗期间全程免疫后感染新型冠状病毒肺炎的风险：一项研究网络分析
Cureus. 2023 Jan 20;15(1):e34004. doi: 10.7759/cureus.34004. eCollection 2023 Jan.
7
Computational Simulation Model to Predict Behavior Changes in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Analysis of Two Regional Japanese Populations.预测炎症性肠病患者在COVID-19大流行期间行为变化的计算模拟模型：对两个日本地区人群的分析。
J Clin Med. 2023 Jan 18;12(3):757. doi: 10.3390/jcm12030757.
8
Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review.新冠疫情期间炎症性肠病的管理：文献综述
Middle East J Dig Dis. 2022 Apr;14(2):155-166. doi: 10.34172/mejdd.2022.269. Epub 2022 Apr 30.
9
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).炎症性肠病中新冠病毒病的危险因素：一项基于西班牙炎症性肠病注册数据库（ENEIDA）的全国性病例对照研究（COVID-19-EII）
J Clin Med. 2022 Dec 19;11(24):7540. doi: 10.3390/jcm11247540.
10
COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.新冠病毒与炎症性肠病的长期不良预后无关：一项多中心病例对照研究
Therap Adv Gastroenterol. 2022 Nov 4;15:17562848221132363. doi: 10.1177/17562848221132363. eCollection 2022.
本文引用的文献
1
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.《来自南锡和米兰队列的炎症性肠病患者的 COVID-19 发病和模式》。
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2134-2135. doi: 10.1016/j.cgh.2020.04.071. Epub 2020 Apr 30.
2
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.意大利 IBD 患者中 79 例 COVID-19 的结局：一项 IG-IBD 研究。
Gut. 2020 Jul;69(7):1213-1217. doi: 10.1136/gutjnl-2020-321411. Epub 2020 Apr 30.
3
Elevated interleukin-6 and severe COVID-19: A meta-analysis.白细胞介素-6升高与重症新型冠状病毒肺炎：一项荟萃分析。
J Med Virol. 2020 Nov;92(11):2283-2285. doi: 10.1002/jmv.25948. Epub 2020 Jun 2.
4
Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD.SARS-CoV-2 进入分子 ACE2 和 TMPRSS2 在 IBD 患者肠道中的表达。
Inflamm Bowel Dis. 2020 May 12;26(6):797-808. doi: 10.1093/ibd/izaa085.
Zotero 插件